![](/img/cover-not-exists.png)
246 EUR-1008 (a new pancraetic enzyme product, PEP) was shown to be safe and effective in cystic fibrosis (CF) patients with exocrine pancreatic insufficiency (EPI)
J.E. Heubi, S.R. Boas, K. Blake, S.Z. Nasr, M.S. Woo, G.R. Graff, K.A. Hardy, R. Amaro-Galvez, M. Latino, C. LeeVolume:
6
Year:
2007
Language:
english
DOI:
10.1016/s1569-1993(07)60229-x
File:
PDF, 47 KB
english, 2007